Watchman LAA Closure Device Enrolling by Invitation Phase 4 Trials for Dabigatran etexilate (DB06695)

IndicationStatusPhase
DBCOND0111559 (Watchman LAA Closure Device)Enrolling by Invitation4
clinicaltrials.gov IdentifierTitlePurposeDrugs